Research programme: recombinant interferon beta - XencorAlternative Names: Interferon beta variants
Latest Information Update: 29 Apr 2008
At a glance
- Originator Xencor
- Class Interferons; Recombinant proteins
- Mechanism of Action Interferon beta stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Multiple sclerosis
Most Recent Events
- 25 Aug 2003 Preclinical trials in Multiple sclerosis in USA (unspecified route)